This Super Semiconductor Stock Crushed Nvidia in 2025. Is It a Buy, Sell, or Hold in 2026?

Broadcom reported fiscal Q4 revenue of $18.0 billion (up 28% year-over-year) with AI semiconductor revenue jumping 74% to $6.5 billion and GAAP Q4 profit rising 97% to $8.5 billion; fiscal 2025 GAAP profit was $23.1 billion. Management guided fiscal Q1 2026 AI semiconductor revenue of $8.2 billion (implying 100% year-over-year growth), and the company has secured large custom-AI orders including $21 billion from Anthropic and supply deals for Alphabet TPUs, driving robust demand for its chips and Tomahawk networking switches. Despite strong operating momentum and a 50% share-price gain in 2025, valuation is rich (P/E ≈73.3, P/S ≈26.5), suggesting investors should consider a multi-year holding horizon rather than a short-term trade.

Analysis

Market structure: Broadcom (AVGO) is shifting the data‑center stack from plug‑and‑play GPUs toward bespoke accelerators and high‑performance switching. Direct winners: AVGO, cloud providers buying custom TPUs (GOOGL), and switch makers; losers: generic GPU ASPs and suppliers of commoditized chips. Orders like Anthropic’s $21B (deliveries into late‑2026) signal multi‑year, front‑loaded capex and pricing power in networking and custom ASICs, making supply tight for high‑margin parts through 2026–2027.

Risk assessment: Major tail risks include regulatory action (antitrust or export controls vs. China) and execution slippage (Anthropic/Alphabet order cancellations or manufacturing defects). Near‑term (days–weeks) volatility risk centers on earnings/guidance; medium term (3–12 months) on supply chain and capacity ramp; long term (2–5 years) on commoditization of custom accelerators and margin normalization. Hidden dependency: Broadcom’s win is tied to a few hyperscalers — customer concentration risk where one contract change can swing revenue by multiple percentage points.

Trade implications: Tactical strategy is to capture asymmetric upside while protecting valuation risk — stagger purchases, use volatility to sell calls, or buy deep‑dated call spreads. Cross‑asset: stronger AI capex should tighten IG credit spreads but increase front‑end yields; underweight long duration Treasuries >7y for 3–12 months. Watch NVDA (NVDA) releases as a bifurcating catalyst that can re‑price relative winners quickly.

Contrarian angle: The market prices AVGO for near‑perfect execution (P/E ~73, P/S ~26.5); a miss would be punished hard. Consensus underweights customer‑concentration and execution risk; also underestimates the chance custom ASICs get standardized and margin pressure returns by 2028. Historical parallel: networking booms in prior cycles saw 40–60% over‑runs on valuation then mean‑reversion; expect similar if growth slows.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in Broadcom (AVGO) using dollar‑cost averaging over the next 8–12 weeks; add another 1–2% only if shares drop >15% or forward P/E falls below 50. Hold time horizon 12–36 months; trim to lock gains if AI semiconductor revenue growth decelerates to <30% YoY on two consecutive quarters.
• Implement a pair trade: long AVGO vs short NVDA sized 1:0.6 (dollar neutral) for a 6–18 month trade to capture Broadcom’s custom‑ASIC upside while hedging general GPU market moves; unwind if NVDA reports a new architecture that materially widens throughput/price parity vs custom ASICs.
• Use options to reduce cost/risk: sell 1–3 month covered calls 10–20% OTM on accumulated AVGO to finance position; simultaneously buy a Jan‑2028 AVGO call spread 25–40% OTM (buy nearer strike, sell further strike) to retain convex upside with capped premium outlay.
• Reduce duration exposure in fixed‑income: cut Treasury/corporate bonds >7y by ~20% and redirect into floating‑rate bank loans or 0–3y IG notes for 3–12 months to hedge against front‑loaded AI capex driving higher near‑term yields and tightening credit dynamics.
• Set hard risk triggers: reduce AVGO exposure by 50% if quarterly AI revenue guidance misses by >5% or if a major customer (Alphabet/Anthropic) delays >20% of contracted deliveries (monitor next 90–180 days); resume accumulation only after visible recovery in guidance/shipments.